Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
drugs
4
×
life sciences
national blog main
national top stories
san diego blog main
san diego top stories
4
×
san francisco blog main
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
cancer
eli lilly
medicxi
alder biopharmaceutical
alector
alkermes
allergan
american academy of neurology
amgen
atogepant
What
new
4
×
drug
drugs
fda
advance
approval
approved
arguments
big
bio
biologic
biology
biopharma
cancer
class
commercialized
companies
competitors
congress
congressional
crispr
cytokine
decades
deeper
demonstrating
diego’s
dna
enhanced
executives
feud
fingerprint
genetic
going
group
isn’t
known
later
lead
make
matter
Language
Current search:
drugs
×
new
×
" san diego top stories "
×
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs
